OTC Hub

Cough is one of the most common presentations at the pharmacy counter. It is most often linked to a viral upper respiratory tract infection and is usually mild and self-limiting. Cough may be dry and tickly, tight, chesty, or productive. Acute cough from a viral URTI commonly improves within 2–3 weeks. Post-viral cough and post-COVID cough may persist longer. Other causes to consider include asthma (especially night cough in children), postnasal drip, gastro-oesophageal reflux, whooping cough (pertussis), chronic bronchitis or COPD, ACE inhibitor or other drug-induced cough, smoking-related cough, and, in patients with heart disease or breathlessness on lying flat, a possible cardiac cause. Any cough lasting more than 3 weeks should be referred for GP review, and a chronic cough lasting more than 8 weeks needs medical assessment. OTC cough products offer symptomatic relief only — the overall evidence base for their effectiveness is modest; they should be presented as symptom support rather than proven treatments.

The common cold is a mild, self-limiting viral upper respiratory tract infection. Symptoms include runny or blocked nose, sneezing, sore or scratchy throat, hoarseness, cough, mild headache, aching, ear or sinus pressure, and a general feeling of being unwell. Cold symptoms are gradual in onset and mainly localised to the nose and throat. Most colds improve within 7–10 days, though nasal congestion and cough may persist for up to 2–3 weeks. Influenza (flu) tends to start more suddenly and causes more prominent systemic symptoms: high fever, chills, significant muscle aches, severe headache, malaise, exhaustion, and a dry cough. Flu generally feels considerably worse than a cold. A temperature above around 38°C is less typical of a simple cold — where significant fever or marked systemic symptoms are present, consider flu, COVID, or another infection rather than assuming a common cold. Flu complications are more likely in at-risk groups — very young children, older adults, pregnant women, and those with chronic respiratory, cardiac, renal, or metabolic disease, or immunosuppression. Other differentials to consider include COVID or other respiratory infections (follow current public health guidance); allergic rhinitis if symptoms are watery, sneezing-predominant, and seasonal; sinusitis if facial pain or purulent discharge is prolonged or worsening; acute otitis media in children; asthma or COPD exacerbation triggered by viral infection; meningitis or sepsis in infants or children with concerning systemic signs; and nasal foreign body in children, particularly if there is unilateral purulent discharge without other cold symptoms. OTC treatment is aimed at symptomatic relief — it does not cure the underlying infection.

Sore throat is commonly a symptom of an acute upper respiratory tract infection and may occur alone or alongside cold symptoms such as cough, blocked or runny nose, headache, hoarseness, or fever. Most sore throats are viral in origin and self-limiting, with many improving within around 7 days. Clinical appearance alone cannot reliably distinguish viral from bacterial cause, and scoring tools such as FeverPAIN or Centor criteria, while informative for assessing severity and guiding decisions, are not definitive diagnostic tests. Antibiotics are not routinely needed for most sore throats — any benefit is usually modest and must be weighed against adverse effects and antimicrobial resistance. OTC treatment is mainly aimed at symptom relief. Differentials to consider include viral URTI or common cold; streptococcal pharyngitis or tonsillitis; glandular fever or infectious mononucleosis (particularly in young adults with prolonged malaise, marked fatigue, or significant lymphadenopathy); quinsy or peritonsillar abscess; epiglottitis or serious upper airway disease; laryngitis or hoarseness; oral candidiasis or thrush; reflux or GORD; irritation from smoking, chemicals, or postnasal drip; and rare malignancy concerns when hoarseness or sore throat is persistent with risk factors. NHS Pharmacy First may apply for acute sore throat due to suspected streptococcal infection in eligible patients — always follow the latest NHSE clinical pathway and PGD/protocol.

Heartburn is a burning discomfort felt behind the breastbone or in the upper stomach area, caused by reflux of stomach contents or acid into the oesophagus. It may be associated with a sour or bitter taste in the mouth, regurgitation, belching, bloating, nausea, or upper abdominal discomfort, and is often worse after meals, on bending, when lying down, or at night. Indigestion and dyspepsia are broader terms — distinct from typical heartburn — covering upper GI symptoms including upper abdominal discomfort or pain, bloating, belching, nausea, and a sense of fullness; these symptoms may overlap with reflux but can occur without a burning quality or regurgitation. Occasional or mild symptoms may be suitable for short-term OTC support with lifestyle advice. Persistent, recurrent, severe, new, or atypical symptoms — especially in older patients or those with risk factors — require medical assessment. OTC treatment is aimed at short-term symptom relief and does not address underlying pathology. Important differentials to consider include gastro-oesophageal reflux disease (GORD); functional dyspepsia; peptic ulcer disease; gastritis; oesophagitis; Barrett's oesophagus in those with longstanding reflux; oesophageal stricture or malignancy where red-flag features are present; cardiac chest pain, angina, or acute coronary syndrome — which must be excluded before assuming symptoms are reflux; gallbladder disease; medicine-induced dyspepsia or reflux; pregnancy-related reflux; and reflux or feeding difficulties in infants and children. Do not assume chest or upper abdominal pain is reflux — cardiac and other serious causes must be considered.

Diarrhoea is the frequent passing of loose or watery stools and may occur alongside abdominal cramps, nausea, vomiting, headache, fever, or a general feeling of being unwell. Most acute episodes are self-limiting and are commonly caused by viral gastroenteritis — norovirus is a frequent cause of outbreaks in households, care homes, hospitals, and schools; rotavirus is particularly common in young children — or by food-related illness. The key priorities at the pharmacy counter are assessing hydration status, identifying red flags that require referral, and considering age, vulnerability, travel history, and any medicines the patient is taking. OTC support mainly centres on preventing or treating dehydration and providing short-term symptom control where suitable. Severe, persistent, bloody, post-travel, antibiotic-associated, or dehydration-associated diarrhoea requires referral. Differentials to consider include viral gastroenteritis; food poisoning or bacterial gastroenteritis; traveller's diarrhoea; antibiotic-associated diarrhoea or possible Clostridioides difficile (particularly following antibiotics or hospitalisation); medicine-induced diarrhoea; inflammatory bowel disease; irritable bowel syndrome; overflow or spurious diarrhoea due to faecal impaction (particularly in elderly or frail patients — these patients must not be given loperamide before impaction has been excluded); lactose intolerance or food intolerance; coeliac disease or malabsorption where symptoms are persistent or recurrent; anxiety or stress-related bowel changes; and acute abdominal pathology where severe pain or systemic illness is present. Diarrhoea can be classified by duration — acute diarrhoea has a rapid onset and is usually self-limiting within a few days; persistent diarrhoea lasting more than 2 weeks requires medical assessment; chronic diarrhoea lasting 5 weeks or longer requires full investigation to identify an underlying cause. Giardiasis should be considered after travel to relevant areas — particularly South America, the Far East, and other regions with lower water quality standards. Significant vomiting and diarrhoea increase the risk of dehydration and acute kidney injury — patients taking certain medicines may need sick-day guidance.

Constipation is commonly defined as fewer than three bowel movements per week, difficulty passing stools, straining, passing hard or lumpy stools (Bristol Stool Chart types 1 or 2), a feeling of incomplete evacuation, or a need for manual assistance to defecate. Acute constipation has a recent onset; chronic constipation is generally considered to have lasted more than six weeks. The most common causes are lifestyle-related — low fibre intake, insufficient fluid, and physical inactivity. Drug-induced constipation is an important and often overlooked cause: common culprits include opioids (the most significant), iron supplements, calcium channel blockers (particularly verapamil), tricyclic antidepressants, antipsychotics, antimuscarinic medicines, and aluminium-containing antacids. Opioid-induced constipation (OIC) requires specific management — tolerance does not develop to the constipating effect of opioids, meaning the problem does not improve with continued opioid use; patients on regular opioids should usually have a laxative prescribed prophylactically. Other causes to consider include hypothyroidism, hypercalcaemia, diabetes, Parkinson's disease, spinal cord problems, pelvic floor dysfunction, irritable bowel syndrome, diverticular disease, and structural colonic pathology. Constipation in pregnancy is common due to progesterone slowing gut motility, compounded by iron supplementation. Elderly patients are at particular risk due to reduced mobility, polypharmacy, lower fluid and food intake, and diminished rectal sensation. Faecal impaction with overflow or spurious diarrhoea may present as apparent diarrhoea in constipated elderly or frail patients — loperamide must not be used without excluding impaction. Haemorrhoids and anal fissure may complicate or result from constipation. Bowel obstruction, colorectal cancer, and inflammatory bowel disease must be considered and excluded before attributing constipation to simple functional causes.

Haemorrhoids (piles) are swollen, engorged vascular cushions within and around the anal canal and lower rectum. Internal haemorrhoids develop above the dentate line inside the anal canal; they are usually painless but may bleed and can prolapse through the anal opening. External haemorrhoids develop below the dentate line and present as lumps around the anus, causing discomfort, itching, and significant pain if thrombosis occurs. Common contributing factors include chronic constipation and straining at stool, a low-fibre diet, inadequate fluid intake, prolonged sitting (including time spent on the toilet), sedentary lifestyle, and pregnancy. Haemorrhoids are very common and can affect people of all ages, though they are particularly prevalent in pregnancy, middle age, and in people who are overweight or physically inactive. Presentations at the pharmacy frequently involve embarrassment — sensitive, non-judgemental questioning is important. The most critical clinical priority is to assess rectal bleeding carefully. Bright red blood appearing on toilet paper or on the surface of the stool is typical of haemorrhoid-related bleeding, but rectal bleeding can also indicate serious pathology including colorectal cancer, which must always be considered. Blood mixed in with the stool, dark or tarry stools, or any rectal bleeding that is unexplained or has not been medically assessed requires prompt referral. Important differentials include anal fissure (sharp pain on defaecation, may bleed), perianal skin conditions, pruritus ani, rectal prolapse, inflammatory bowel disease, benign anorectal polyps, and colorectal cancer.

Threadworms (Enterobius vermicularis) are the most common intestinal worm infection in the UK and are particularly prevalent in school-age children, though they can affect people of any age. The adult worms are small, white, and thread-like — typically 2–13 mm in length. Female worms migrate from the bowel to the perianal skin at night to deposit eggs, causing the characteristic intense itching around the anus, particularly at night. Scratching transfers eggs to the hands and nails, and reinfection or spread to other household members occurs readily through contaminated hands, surfaces, food, bedding, and clothing. Eggs can survive on surfaces for up to two weeks. Symptoms include perianal itching, disturbed sleep, and in children, restlessness and irritability. Girls and women may experience vulval or vaginal irritation if worms migrate to that area. Abdominal discomfort can occur but is not a predominant feature. Some individuals, particularly those with light infections, may be entirely asymptomatic. The condition is almost always benign and self-limiting in healthy individuals, and OTC treatment is effective. However, hygiene measures are essential alongside any pharmacological treatment — without them, reinfection is likely. All close household contacts are usually advised to be treated simultaneously regardless of whether they have symptoms, as asymptomatic carriage is common. The primary OTC treatment is mebendazole, which is licensed from the age of 2 years. Piperazine-containing preparations offer an alternative where mebendazole is not suitable. Neither is licensed for use in the first trimester of pregnancy.

Motion sickness is caused by a conflict between sensory inputs: the inner ear detects movement while the eyes may perceive a stationary environment, or vice versa. This sensory mismatch triggers a characteristic cluster of symptoms including nausea, vomiting, pallor, cold sweats, dizziness, and general malaise. Symptoms typically begin during travel — car, boat, plane, train, or amusement rides — and resolve once the motion stops, though recovery can take hours after a prolonged sea voyage. Some individuals are considerably more susceptible than others; susceptibility is highest in children aged 2 to 12 years and tends to reduce in older adolescents and adults, though adults can be significantly affected. Repeated exposure to the same type of travel can lead to gradual adaptation in some patients. Non-pharmacological measures — appropriate seating, focusing on the horizon, fresh air, and avoiding triggers — are useful first-line strategies and can be combined with pharmacological treatment. The main OTC options are hyoscine hydrobromide (an anticholinergic) and sedating antihistamines (cinnarizine, promethazine, dimenhydrinate, and cyclizine). Preventive treatment taken before travel begins is significantly more effective than treating established symptoms. The sedating and anticholinergic side effects of these medicines have important clinical implications — they must not be used before or during driving or operating machinery, and interactions with other CNS-depressant medicines and alcohol must be checked. Vertigo of vestibular origin (inner ear pathology) may present similarly to motion sickness but is not improved by travel sickness medicines in the same predictable way and requires medical assessment if persistent or recurrent.

Nausea and vomiting are symptoms that can arise from a wide range of causes — from self-limiting viral gastroenteritis to serious conditions requiring urgent assessment. The pharmacy role in nausea and vomiting is primarily to screen for red flags, support hydration, and refer appropriately. OTC antiemetic medicines have a very limited role outside of clearly travel-related vomiting and, in some cases, pregnancy-related nausea where non-drug measures have not helped. Most acute episodes of nausea and vomiting in otherwise healthy adults are caused by viral gastroenteritis or food poisoning and are self-limiting. Common additional causes include motion sickness, migraine, pregnancy, medication side effects, excess alcohol, and pain. More serious causes to screen for include gastrointestinal obstruction, peptic ulcer disease, raised intracranial pressure, meningitis, diabetic ketoacidosis, appendicitis, and acute coronary syndromes — all of which can present with nausea and vomiting. The most important immediate risk in vomiting is dehydration and electrolyte imbalance, which is particularly dangerous in infants, young children, the elderly, and patients with diabetes or renal disease. Oral rehydration salts (ORS) are the primary OTC product for managing dehydration associated with vomiting and diarrhoea. Patients on medicines that require stable absorption or that are nephrotoxic should be given sick-day guidance. Persistent or unexplained vomiting, vomiting with blood or bile, severe abdominal pain, systemic illness, or any neurological symptoms must be referred.

Irritable bowel syndrome (IBS) is a common functional gut condition characterised by recurrent abdominal discomfort or pain associated with altered bowel habit. Symptoms may include constipation, diarrhoea or a mixed pattern, along with bloating, wind, urgency and mucus in stool. Symptoms often fluctuate and may be influenced by diet, stress and lifestyle. OTC products can help manage specific symptoms but do not confirm or treat an underlying diagnosis. Red flags must be screened for before attributing symptoms to IBS — new, persistent or worsening symptoms always warrant medical assessment.

Hay fever (seasonal allergic rhinitis) is an IgE-mediated allergic response to airborne pollen. The main pollen seasons in the UK are tree pollen (February to early June, peaking around April to May), grass pollen (mid-May to July — the most prevalent cause of hay fever), and weed pollen (June to September). Symptoms result from allergic inflammation of the nasal mucosa and conjunctiva following pollen exposure. Typical nasal symptoms include repeated sneezing, itching inside the nose, a clear runny or blocked nose, and postnasal drip. Postnasal drip can cause a tickly throat, an irritating cough, or a persistent sensation of mucus at the back of the throat. Ocular symptoms include itching, watering, redness, and puffiness of the eyes. Symptoms are usually bilateral, seasonal, and recurrent year on year in line with the patient's pollen triggers. Hay fever is a significant cause of reduced quality of life — disrupting sleep, impairing concentration, affecting school and work performance, and making outdoor activities difficult. It is strongly associated with asthma and can substantially worsen asthma control during the pollen season. Distinguishing hay fever from perennial allergic rhinitis (year-round symptoms commonly triggered by house dust mite, pet dander, or mould) matters clinically — the management principles overlap but the pollen avoidance advice and timing of treatment differ. Sinusitis or upper respiratory infection should be considered when there is facial pain, fever, purulent discharge, or worsening one-sided symptoms. Unilateral nasal symptoms, blood-stained discharge, or persistent blocked nose not consistent with a simple allergic pattern always need further assessment.

Headache is one of the most common presentations at the pharmacy counter. Most headaches in otherwise well adults are benign and self-limiting, but screening for red flags before making any OTC recommendation is essential. Tension-type headache is the most common type — typically bilateral, pressure-like or band-like, mild to moderate in severity, and not worsened by routine physical activity. Migraine is episodic, usually moderate to severe, often unilateral, and has a pulsating or throbbing quality that is worsened by routine activity. It is frequently accompanied by nausea or vomiting and by sensitivity to light (photophobia) or sound (phonophobia); some episodes are preceded by an aura, most commonly visual symptoms such as zigzag lines, flashing lights, or a spreading blind spot. Medication overuse headache (MOH) — also called analgesic overuse headache — is an important and under-recognised cause of frequent or daily headache: it develops when analgesics are taken on 10 or more days per month; the headache pattern progressively worsens despite increasing analgesic use; management involves gradual withdrawal of the overused analgesic under GP guidance. General musculoskeletal pain including back pain, joint pain, muscle strain, and soft tissue injuries is also commonly presented at the pharmacy counter. Cluster headache causes severe, strictly unilateral, periorbital pain with autonomic features; it is not managed with OTC analgesics and should be referred for specialist assessment. In patients over 50 with a new headache, temporal arteritis (giant cell arteritis) must be considered if there is scalp tenderness, jaw pain on chewing, or visual changes — this is a medical emergency requiring same-day referral.

Minor musculoskeletal problems — sprains, strains, soft tissue injuries and simple aches — are common reasons for seeking pharmacy advice. OTC analgesics, topical preparations, heat or cold therapy and supportive measures can help manage mild, self-limiting symptoms. However, a wide range of red flags must be screened for before advising self-care, including suspected fracture, neurological symptoms, red/hot/swollen joints, back pain with bladder or bowel symptoms, features of DVT, post-fall injury in older people, and pain that is severe, worsening or not responding to treatment. NSAID and paracetamol safety checks are essential for every consultation.

Mouth ulcers (aphthous ulcers) are painful, shallow breaks in the oral mucosa that typically affect the inside of the cheeks, lips, tongue, floor of the mouth, or soft palate. Most are minor, self-limiting, and resolve within one to two weeks without treatment. They can make eating, drinking, and speaking uncomfortable. Common triggers include minor trauma such as cheek or tongue biting, sharp tooth edges, ill-fitting dentures, orthodontic appliances, stress, and intercurrent illness. Nutritional deficiencies — particularly iron, folate, and vitamin B12 — can cause recurrent oral ulceration and should be considered in patients with frequent or persistent episodes. Certain medicines are recognised causes, including NSAIDs, nicorandil, methotrexate, cytotoxic medicines, and some immunosuppressants. In patients using inhaled corticosteroids, apparent mouth ulcers may represent oral candidiasis rather than true ulceration. Recurrent or severe oral ulceration may also be associated with inflammatory bowel disease, coeliac disease, Behçet's disease, or other systemic conditions. The most important clinical priority is to distinguish simple aphthous ulceration from oral conditions that require prompt referral — in particular any ulcer lasting more than three weeks without healing, an unexplained single persistent ulcer, a lump, or a red or white patch in the mouth, all of which may indicate oral cancer. Oral cancer risk is significantly increased by tobacco use and excess alcohol. A careful history is essential before advising OTC management.

Head lice (Pediculus humanus capitis) are small, wingless parasitic insects that live on the human scalp and feed on blood. They are spread almost exclusively by direct head-to-head contact — they cannot fly, jump, or survive for long away from the scalp. Spread through sharing combs, hats, or bedding is possible but much less common. Head lice infestation is most common in school-age children but affects people of all ages. Itching of the scalp is a common symptom but does not always occur — it results from an allergic reaction to louse saliva and may not develop for several weeks after infestation. The absence of itching does not exclude active infestation. Nits are the empty or viable egg cases attached to hair shafts close to the scalp; their presence alone does not confirm an active infestation, as they may be remnants from a previous infection. Active infestation is confirmed only by finding live, moving lice — best done using a fine-toothed detection comb on wet, conditioned hair. Treatment should only be started where live lice have been found. There are two main OTC approaches: physical-action products (which suffocate or disrupt the waxy coating of lice and are considered first-line) and chemical insecticides (such as malathion, where physical products have failed or are not suitable). Resistance to pyrethroid insecticides is widespread in the UK, meaning older insecticide-based products are no longer recommended as first-line. All close head-to-head contacts of the affected person should be checked for live lice at the same time, and those found to have active infestation should be treated simultaneously.

Nappy rash (napkin dermatitis) is one of the most common skin conditions in infants and young children. The most frequent type is irritant contact dermatitis, caused by prolonged contact of the skin with urine and faeces in the nappy area, compounded by moisture, friction, and occasional exposure to irritants in wipes, soaps, or creams. Characteristic features of irritant nappy rash are redness and inflammation on the convex surfaces of the nappy area — the buttocks, inner thighs, and genitalia — with relative sparing of the skin folds. Candidal nappy rash should be suspected when the rash is bright red, involves and extends into the skin folds, has a slightly raised scaly margin, and is accompanied by satellite lesions (small red spots or pustules beyond the main rash edge). Candidal nappy rash often follows a course of antibiotics or persistent diarrhoea. Bacterial secondary infection should be considered if there are pustules, crusting, weeping, blistering, fever, or a rapidly worsening rash. Prevention and management focus on reducing moisture and irritant contact: frequent nappy changes, careful gentle cleansing, adequate drying, and regular application of a barrier preparation. Where candidal features are present, an antifungal cream is added to the regimen. Topical steroids should not be applied to nappy rash without specific medical direction — many combined steroid-antifungal preparations designed for other body areas are not appropriate for use in the nappy area on infants. The decision to supply an antifungal cream OTC for suspected candidal nappy rash should be made carefully, with referral if there is any uncertainty, the baby appears unwell, or standard measures are not working.

Eczema and dermatitis are terms that describe a pattern of inflammatory skin disease characterised by dryness, itching, redness, and variable degrees of scaling, cracking, weeping, and crusting. Atopic eczema is a chronic, relapsing condition with a genetic predisposition and is strongly associated with asthma and allergic rhinitis. It commonly begins in childhood and may continue into adult life. Irritant contact dermatitis arises from direct skin exposure to substances that physically damage the skin barrier — soaps, detergents, solvents, frequent wet work, rubber gloves, and occupational chemicals are common culprits. Allergic contact dermatitis is a type IV delayed hypersensitivity reaction to a specific sensitiser; common allergens include nickel (from jewellery and clothing fasteners), fragrances, preservatives in topical products, rubber accelerators, and hair dye components. At the pharmacy counter, the most common OTC presentations are patients managing a known flare of diagnosed atopic eczema or patients with dry, itchy, or irritated skin that may represent early or mild contact dermatitis. Emollients are the cornerstone of all eczema management — they should be applied frequently and regularly throughout the day, both during flares and between them, as a preventive measure. Soap substitutes replace irritant cleansers and reduce daily barrier disruption. OTC hydrocortisone 1% can be used for short-term management of mild-to-moderate inflammatory flares on suitable areas of skin in appropriate patients. Infection is the most important immediate complication of eczema to identify and refer: secondary bacterial infection (most commonly Staphylococcus aureus) causes weeping, crusting, spreading redness, warmth, and pain, and requires antibiotic treatment. Eczema herpeticum — viral infection of eczematous skin with herpes simplex virus — is a medical emergency: a patient with eczema who develops a suddenly worsening painful rash with punched-out blisters or erosions and systemic illness requires same-day emergency assessment.

Acne vulgaris is a common, chronic inflammatory condition of the pilosebaceous unit. It is most prevalent in adolescence and early adulthood but can persist into or first present in adult life, particularly in women. The key pathological processes are increased sebum production, abnormal follicular keratinisation causing blockage, colonisation and overgrowth of Cutibacterium acnes (formerly Propionibacterium acnes), and subsequent inflammation. Non-inflammatory lesions (comedones) include open comedones (blackheads) and closed comedones (whiteheads). Inflammatory lesions include papules and pustules; in more severe disease, nodules and cysts form, which carry a significant risk of scarring. Acne most commonly affects the face, and may also involve the chest, back, and shoulders. The psychological impact of acne should not be underestimated — it causes significant distress, affects self-esteem and social functioning, and is associated with anxiety and depression, particularly in adolescents. OTC treatment is appropriate for mild-to-moderate acne characterised by comedones and limited papules and pustules. Severe acne — involving widespread inflammatory lesions, nodules, cysts, or early scarring — requires prescriber assessment and is not appropriate for OTC management alone. The key OTC active ingredients are benzoyl peroxide and salicylic acid. Adapalene 0.1% gel is available as a Pharmacy medicine in the UK for mild-to-moderate acne. OTC treatments typically require consistent use for 6 to 8 weeks before significant improvement is seen; patients should be counselled about this timeline to prevent premature discontinuation.

Fungal skin infections (tinea or dermatophytosis) are among the most common dermatological presentations at the pharmacy counter. The three most frequently encountered conditions suitable for OTC management are athlete's foot (tinea pedis), ringworm (tinea corporis), and fungal groin infection (tinea cruris). All are caused by dermatophyte fungi that infect the keratinised layers of the skin, hair, and nails. Athlete's foot typically presents as itching, scaling, fissuring, and maceration between the toes, and may spread to the soles and sides of the foot. The interdigital form is most common; a vesicular type with blisters may occur; the moccasin type causes diffuse fine scaling over the sole. Ringworm presents as one or more ring-shaped, scaly, red, itchy patches on the body or limbs with a well-defined edge and a tendency to spread outwards with some central clearing. Tinea cruris affects the inner thighs and groin, producing a clearly demarcated red scaly rash that usually spares the scrotum (which helps distinguish it from candidal intertrigo, where the scrotum is typically involved). Tinea infections are spread by direct contact with infected people, animals, soil, or contaminated surfaces. Warm, moist environments, shared changing facilities, sports and gym use, communal bathing, and inadequate foot hygiene are risk factors. Secondary bacterial infection can complicate any tinea infection, presenting with increased pain, swelling, warmth, pus, and systemic features. Fungal nail infection (onychomycosis) and scalp ringworm (tinea capitis) are not suitable for OTC management and require prescriber assessment and oral antifungal treatment.

Warts and verrucae are benign epidermal skin lesions caused by human papillomavirus (HPV). Common warts (verruca vulgaris) typically appear as rough, raised, flesh-coloured or grey lesions with an irregular surface, most commonly on the hands and fingers. Plantar warts (verrucae) occur on the sole of the foot and are driven inward by body weight, making them flat or slightly raised with a rough surface; they may have small black dots (thrombosed capillaries) within them and can be painful on weight-bearing. The virus is spread by direct contact and via contaminated surfaces — communal changing rooms, swimming pools, gym floors, and shared towels are common transmission environments. Many warts resolve spontaneously, particularly in children, although this can take months or years. Treatment is not always necessary for asymptomatic lesions, but is appropriate where warts are painful, numerous, spreading, cosmetically troubling, or where the patient wishes them removed. OTC treatment options include salicylic acid preparations (the most evidence-based first-line option) and cryotherapy devices. It is important to distinguish warts and verrucae from other foot lesions: corns and calluses are areas of thickened skin caused by friction or pressure, without the disrupted skin lines, black dots, or papillomatous surface characteristic of verrucae; a corn typically has a central hard core and is painful with direct pressure. Any rapidly changing, pigmented, bleeding, or atypical skin lesion requires referral to exclude more serious pathology. Patients with diabetes or peripheral vascular disease should not use keratolytic or cryotherapy treatments on their feet without medical advice due to the risk of ulceration.

Sunburn is an acute inflammatory skin reaction caused by overexposure to ultraviolet (UV) radiation, primarily UVB. It causes erythema (redness), pain, heat, and tenderness in the exposed areas, with peeling following in the days after. Sunburn can range from mild redness to severe blistering with systemic symptoms. Mild sunburn causes superficial erythema and discomfort that typically peaks at 12 to 24 hours after exposure and resolves over several days. Severe sunburn involves blistering, significant swelling, intense pain, and may be accompanied by fever, chills, nausea, headache, dizziness, or dehydration — this degree of sunburn requires medical assessment. Babies and young children have thinner, more vulnerable skin, a higher skin surface area to body weight ratio, and less capacity to regulate temperature — sunburn in infants and young children should always be taken seriously. Photosensitising medicines — including certain antibiotics (particularly doxycycline and ciprofloxacin), diuretics (thiazides), NSAIDs, amiodarone, and some antifungals — significantly increase sunburn risk and can cause severe reactions at sun exposures that would not normally cause problems. Heat exhaustion and heatstroke are separate but potentially concurrent conditions caused by thermal overloading — a patient with signs of heat exhaustion (heavy sweating, pale skin, dizziness, nausea, headache, muscle cramps) or heatstroke (confusion, hot dry skin, loss of consciousness, high temperature) alongside sunburn requires emergency assessment. In the longer term, repeated sunburn is strongly associated with increased risk of skin cancer, including melanoma. Any changing, irregularly pigmented, or otherwise suspicious skin lesion noticed during or after sun exposure should be referred.

Scabies is an intensely itchy skin infestation caused by the mite Sarcoptes scabiei. The itch is typically worse at night. Burrows and a generalised allergic rash may develop, most commonly affecting the finger webs, wrists, elbows, armpits, waist, buttocks and genital area. Face and scalp are usually spared in adults but may be affected in babies. Spread is through prolonged close skin-to-skin contact. All household and close contacts must be treated at the same time as the affected person to prevent re-infestation. Symptoms may persist for several weeks after successful treatment due to an ongoing allergic reaction — this does not mean treatment has failed.

Dandruff is a common, non-contagious condition characterised by flaking and itching of the scalp. It is associated with Malassezia yeast overgrowth and sebum production. Mild dandruff can usually be managed with medicated OTC shampoos. Seborrhoeic dermatitis of the scalp is a more inflamed variant and may affect the face, eyebrows, ears and chest as well. Referral is appropriate where the diagnosis is uncertain, where there is significant inflammation, signs of infection, patchy hair loss or no improvement after a suitable trial of medicated shampoo.

Excessive sweating (hyperhidrosis) is sweating beyond what is needed for normal temperature regulation. It most commonly affects the underarms, palms, soles of the feet and face, often on both sides symmetrically. Primary focal hyperhidrosis has no underlying medical cause and usually starts in younger people. Secondary hyperhidrosis can be caused by infection, endocrine conditions (thyroid disease, diabetes, menopause), medicines or systemic illness and requires medical assessment. OTC high-strength antiperspirants and lifestyle adjustments can support primary focal sweating. Systemic symptoms, night sweats, weight loss or one-sided sweating always require referral.

Psoriasis is a chronic inflammatory skin condition characterised by well-defined, raised red plaques covered with silvery-white scale. It most commonly affects the elbows, knees, scalp and lower back but can occur anywhere, including the nails and genitals. Psoriasis follows a relapsing and remitting course; flares may be triggered by stress, skin injury, infection or certain medicines. Joint involvement (psoriatic arthritis) occurs in a significant proportion of people with psoriasis. OTC support — emollients, scale-softening preparations and coal tar products — can help manage mild disease and support skin between flares, but new presentations, severe or widespread disease, joint symptoms and infected plaques all require medical assessment. Psoriasis can have a significant impact on psychological wellbeing.

Hair loss has many causes. Gradual diffuse thinning in a characteristic pattern (androgenetic alopecia — male or female pattern hair loss) is the most common type and the one most amenable to OTC support. Sudden hair loss, patchy hair loss, scarring or an inflamed scalp all require medical assessment before any OTC product is considered. Contributory factors include medicines, nutritional deficiency, thyroid disease, iron deficiency, recent illness, stress, significant weight loss and hormonal changes. Hair loss can have a significant psychological impact. OTC topical minoxidil is available as a pharmacy medicine for pattern hair loss where the product licence supports its use — this page is a professional reference guide, not a supply eligibility tool.

Urticaria (hives) presents as itchy raised wheals or weals that can appear anywhere on the body. The rash typically moves around, changes shape, and individual lesions resolve within 24 hours. It can be triggered by foods, medicines, insect stings, infection, heat, cold, pressure, or stress — or may have no identifiable trigger. Acute urticaria lasts less than 6 weeks; chronic urticaria persists beyond 6 weeks. The pharmacy role is to assess severity, screen for signs of anaphylaxis or angioedema, identify possible triggers, provide OTC antihistamine support where appropriate, and refer promptly when red flags are present. Do not attempt to diagnose the cause.

Prickly heat (miliaria) is a common itchy rash caused by blockage of sweat glands, typically occurring after heat exposure and sweating. It most commonly affects covered or sweaty areas — the neck, chest, back, armpits, groin and skin folds. It is particularly common in hot or humid weather, during travel to warm climates, in newborns and young children, and in people who wear occlusive clothing or use heavy creams. The rash usually resolves when the skin is cooled and the triggering heat exposure stops. The pharmacy role is to assess whether the rash is prickly heat or a different condition requiring referral, and to advise on cooling, self-care, and appropriate OTC products where suitable.

Vaginal thrush (vulvovaginal candidiasis) is a common fungal infection caused most frequently by Candida albicans. Typical symptoms include vulval itching, soreness, burning, and redness; the vulva and vaginal opening may appear inflamed. A thick, white, odourless discharge resembling cottage cheese is classically described, but discharge may be absent, minimal, or vary in consistency. External dysuria — stinging on urination as urine contacts the inflamed vulval skin — is common and must be distinguished from internal dysuria suggesting a urinary tract infection. OTC treatment is appropriate for a limited group of patients: those aged 16 to 60 years who have previously been diagnosed with vaginal thrush by a clinician and whose current symptoms are clearly consistent with a recurrence. The most important clinical priority is ensuring this is not being supplied for a first-ever episode (where the diagnosis is uncertain) and ruling out symptoms that suggest an alternative or concurrent diagnosis. Symptoms of bacterial vaginosis, sexually transmitted infections, atrophic vaginitis, contact dermatitis, or early pregnancy can overlap with thrush and must be screened for by history. Pelvic or lower abdominal pain, offensive or discoloured discharge, abnormal vaginal bleeding, genital sores or blisters, fever, or systemic illness all require referral. Recurrent vulvovaginal candidiasis — defined as four or more confirmed episodes within twelve months — requires medical assessment to identify predisposing causes such as diabetes, immunosuppression, or non-albicans Candida species, and is not appropriate for OTC management.

Period pain (dysmenorrhoea) is cramping lower abdominal or pelvic pain during or just before menstruation. Primary dysmenorrhoea occurs in the absence of a detectable pelvic condition and is most common in younger people in the years following the first period. Secondary dysmenorrhoea is caused by an underlying condition such as endometriosis, fibroids or infection and may need investigation. OTC analgesics and heat therapy can support primary dysmenorrhoea; new, worsening or atypical pain patterns should prompt referral.

Premenstrual syndrome (PMS) describes a range of physical and emotional symptoms that occur in the days before a period and typically improve once menstruation begins or shortly after. Symptoms include bloating, breast tenderness, headache, mood changes, irritability, anxiety and tiredness. Mild-to-moderate PMS can be supported with lifestyle advice and OTC symptomatic relief. Severe symptoms — particularly severe mood disturbance or those not clearly linked to the menstrual cycle — require GP assessment. Premenstrual dysphoric disorder (PMDD) is a more severe form and falls outside OTC management.

The menopause marks the end of menstruation, typically around age 51 in the UK. Perimenopause is the transitional phase before this and may last several years. Common symptoms include hot flushes, night sweats, sleep disturbance, mood changes, vaginal dryness, urinary symptoms, reduced libido and joint or muscle aches. The severity and impact vary widely. OTC support can help with vaginal dryness and comfort, and lifestyle measures may reduce the impact of vasomotor symptoms. Referral for GP-led menopause review — including discussion of HRT — is appropriate when symptoms are moderate to severe or significantly affect quality of life. No HRT prescribing or hormonal treatment pathway is included here.

Emergency contraception (EC) can reduce the chance of pregnancy after unprotected sex or contraceptive failure. The copper IUD is the most effective option and requires urgent referral or signposting to an appropriate service. Oral emergency hormonal contraception (EHC) options may be available as a pharmacy supply where the product licence, local PGD, private service protocol and professional judgement support supply. This page is a professional reference guide — it does not replace product-specific assessment, local SOPs or the pharmacist's clinical judgement. Every consultation must be conducted in private.

Desogestrel is a progestogen-only pill (POP) available as a pharmacy medicine (P) in the UK where the product licence and current regulatory status support OTC supply. It is taken daily for ongoing contraception. This page is a professional reference guide to support the pharmacist's assessment — it does not create a supply eligibility engine or replace the product licence checklist, local SOP or pharmacist's clinical judgement. All supply decisions must be made within the product licence, professional standards and applicable pharmacy protocols.

Pregnancy brings a range of common minor symptoms that often present to pharmacy. These include nausea and vomiting, heartburn and reflux, constipation, haemorrhoids, minor pain and fever, urinary symptoms and vaginal discomfort. Many OTC medicines require pregnancy-specific licence and safety checks — gestation matters, and suitability varies by trimester. Non-pharmacological measures are often first-line. Several red flags require urgent referral, including vaginal bleeding, severe abdominal pain, features suggesting pre-eclampsia, persistent vomiting with dehydration, reduced fetal movement in later pregnancy, and UTI symptoms. Every medicine supply to a pregnant person requires product-specific safety confirmation.

Heavy menstrual bleeding (HMB) is a common presentation in pharmacy. It can significantly affect quality of life and may indicate an underlying gynaecological or systemic cause requiring medical assessment. The pharmacy role is to assess red flags, support symptom management with OTC options where appropriate, raise awareness of anaemia risk, and refer for investigation. Do not attempt to diagnose the cause or recommend hormonal or prescription treatments.

Oral thrush (oral candidiasis) is a fungal infection of the mouth caused by Candida species, most commonly Candida albicans. The most recognisable form — pseudomembranous candidiasis — presents as creamy white or yellowish plaques or patches on the oral mucosa (inner cheeks, tongue, palate, or gums) that can be wiped away, leaving a red or raw, sometimes bleeding, surface beneath. Erythematous oral candidiasis presents as redness and soreness without obvious white patches and is commonly seen in patients using inhaled corticosteroids. Angular cheilitis — cracks, soreness, and redness at the corners of the mouth — may occur alongside oral thrush or independently. Risk factors for oral candidiasis include use of inhaled corticosteroids without rinsing the mouth afterwards, broad-spectrum antibiotic use, wearing full dentures (particularly overnight), dry mouth from any cause, diabetes, immunosuppression, extremes of age, smoking, and high sugar intake. Oral thrush in an otherwise healthy adult with a clear precipitating cause (such as recent antibiotics or inhaled corticosteroid use) is appropriate for OTC management. However, recurrent or persistent oral thrush, thrush in an immunosuppressed patient, suspected oesophageal involvement, or any oral lesion that cannot be wiped off requires prompt referral — persistent white or red patches in the mouth that cannot be attributed to candidiasis may indicate leukoplakia, erythroplakia, lichen planus, or oral cancer. The key OTC treatment is miconazole 2% oral gel. Nystatin is available as a licensed antifungal but is only available on prescription in the UK and is not an OTC product.

Cold sores are caused by herpes simplex virus type 1 (HSV-1), though HSV-2 can occasionally cause facial lesions. After primary infection — which often occurs in childhood and may be asymptomatic or present as gingivostomatitis — the virus remains latent in the trigeminal nerve ganglion and can reactivate throughout life. Recurrent cold sores typically appear around the lips and perioral skin, beginning with a prodromal phase of tingling, burning, or itching before visible lesions develop. Fluid-filled blisters then form, rupture to leave shallow crusted ulcers, and heal over 7 to 10 days without scarring. Common triggers for reactivation include UV light exposure, physical or emotional stress, intercurrent illness, fever, fatigue, and hormonal changes. Cold sores are highly contagious during the active phase — viral shedding is highest when blisters are present and continues until healing is complete. Transmission occurs through direct contact with lesions or secretions and through sharing items such as cups, cutlery, towels, and lip products. Cold sores are distinct from mouth ulcers (aphthous ulcers), which occur inside the mouth on non-keratinised mucosa and are not caused by herpes simplex. Impetigo (bacterial infection) can sometimes be confused with cold sores — it tends to produce honey-coloured crusted lesions and responds to antibiotics rather than antivirals. OTC antiviral creams (aciclovir 5% and penciclovir 1%) are most effective when started at the earliest sign of symptoms during the prodromal phase. Starting treatment during the blister or crust stage reduces the benefit. The most important safety priorities are to identify eye involvement or peri-ocular lesions (which require urgent referral), eczema herpeticum in patients with atopic eczema (a medical emergency), and presentations in immunosuppressed patients, newborns, or young infants.

Toothache is dental pain that requires dental assessment to identify and treat the underlying cause. It cannot be cured by pharmacy products. Common causes include dental caries (tooth decay), dental abscess, cracked or fractured tooth, exposed dentine causing hypersensitivity, pericoronitis (inflammation around a wisdom tooth), gum disease, or loss of a filling or crown. The pharmacy role is to provide safe and appropriate interim pain relief, screen for red flags requiring urgent referral, and direct the patient to dental services — NHS 111 for urgent dental advice, NHS dentist for routine assessment, or emergency dental services where urgent care is needed. The most important red flags are signs of a spreading dental infection or abscess: facial swelling, swelling extending to the eye or neck, difficulty breathing or swallowing, trismus (inability to fully open the mouth), fever, and systemic illness. A dental abscess that has not been drained is not resolved by antibiotics alone, though they may be prescribed as adjuncts; the definitive treatment is drainage. A patient with breathing or swallowing difficulty from a spreading infection is a medical emergency requiring 999. Antibiotics should never be recommended or supplied OTC for toothache — they are not appropriate without dental assessment and prescription. For pain relief, ibuprofen is particularly effective for dental pain due to its anti-inflammatory properties, though paracetamol or a combination may be used. Topical anaesthetic products (benzocaine gels, clove oil preparations) provide temporary relief only and do not treat the underlying problem. Dental sensitivity toothpastes and temporary filling repair kits can provide symptomatic support pending dental assessment.

Lower urinary tract symptoms (LUTS) in men include both storage symptoms (frequency, urgency, nocturia) and voiding symptoms (hesitancy, weak stream, straining, dribbling, incomplete emptying). While benign prostatic enlargement (BPE) is a common cause in older men, symptoms alone cannot confirm a diagnosis and several red flags — including haematuria, urinary retention, infection, and features suggesting prostate cancer — require prompt referral. OTC support is limited; lifestyle adjustments may help mild symptoms, and medicine review is relevant where current medicines may be contributing. Assessment by a GP or urology service is appropriate for persistent or worsening LUTS.

Urinary incontinence — the involuntary leakage of urine — is common and often under-reported due to embarrassment. Symptom patterns include stress incontinence (leakage with cough, sneeze or exercise), urge incontinence (sudden uncontrollable urge), mixed symptoms, and overflow-type leakage. Incontinence affects people of all ages and all sexes, although the causes and underlying factors differ. OTC support is limited but practical: continence products, pelvic floor guidance and bladder diary tools. Red flags — including haematuria, UTI features, neurological symptoms, sudden onset, urinary retention and diabetes symptoms — require prompt referral. The consultation should be conducted with sensitivity and privacy.

Erectile dysfunction (ED) is the persistent difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. It is common and increases in prevalence with age. ED may have vascular, neurological, hormonal, psychological or medicine-related causes, and can be an early marker of underlying cardiovascular disease, diabetes or other systemic conditions. OTC sildenafil (a P medicine) is available in the UK for men aged 18 and over where the product licence, pharmacy supply protocol and professional assessment support its use. This page is a professional reference guide — it does not create a supply eligibility engine or replace the product protocol, local SOP, or pharmacist's clinical judgement. All consultations should be conducted in private.

Red eye is a common presenting complaint with a wide range of causes — from mild conjunctival irritation and allergic conjunctivitis to serious conditions requiring urgent assessment, including uveitis, keratitis, acute angle-closure glaucoma and herpes simplex eye infection. The key discriminators are eye pain, photophobia, vision change and the presence of contact lenses. Simple bilateral watery or itchy redness in an otherwise well person with clear history of allergy is lower risk. Any painful, photophobic or vision-affected red eye, and any red eye in a contact lens wearer, requires urgent referral to optometrist or emergency eye service. This page does not create a diagnosis engine — it supports appropriate triage and signposting.

Dry eye is a common condition characterised by a deficiency of the tear film causing symptoms of dryness, grittiness, burning, stinging and tired or uncomfortable eyes. Paradoxically, watery or reflex tearing can occur as the eye responds to dryness. Contributing factors include prolonged screen use, dry or air-conditioned environments, contact lens wear, age, menopause, certain medicines (antihistamines, antidepressants, anticholinergics, isotretinoin, diuretics) and systemic conditions such as Sjögren's syndrome. OTC lubricating drops, gels and ointments are first-line. Pain, photophobia, vision change and contact-lens-related red eye are red flags that require referral, not OTC management.

Common ear problems presenting to pharmacy include earwax build-up, pressure-related discomfort, mild external ear irritation and earache. Earwax is the most frequent OTC presentation — softening drops can help in the absence of contraindications. Many ear symptoms — including discharge, severe pain, sudden hearing loss, dizziness and fever — are red flags requiring referral. Ear drops must never be used if there is a perforated eardrum, grommets, recent ear surgery or discharge without prior medical advice. Acute otitis media (AOM) in children has a separate Pharmacy First pathway in LocumPilot and should be managed through that route where it applies — this page covers general ear symptom support and triage only.

Infantile colic describes episodes of inconsolable crying and apparent distress in an otherwise healthy, well-fed infant, typically in the first few months of life. The baby may draw up their legs, clench their fists and appear to be in pain. Episodes often follow a pattern — particularly in the evening — but the cause is not fully understood. The diagnosis is one of exclusion — red flags must be screened for carefully. Evidence for most colic remedies is limited. Parental and carer reassurance and support are central to management. Symptoms usually resolve spontaneously by 3–4 months of age.

Teething is the process of primary teeth erupting through the gums, typically beginning from around 6 months and continuing through the first 2–3 years of life. Common associated symptoms include increased dribbling, chewing and mouthing of objects, gum discomfort, mild irritability and disturbed sleep. Teething does not cause high fever, significant diarrhoea, serious illness or breathing problems — symptoms attributed to teething that cross these boundaries should prompt assessment to exclude other causes. Non-drug comfort measures are first-line. OTC medicines for teething should be used according to product licence and age restrictions, and not relied upon as a substitute for assessing whether the child is well.

Childhood rashes are common pharmacy presentations and are frequently viral and self-limiting. However, the pharmacist's priority is to identify red flags that indicate serious illness — particularly meningococcal disease, sepsis and severe dehydration. Do not attempt to diagnose the specific rash. Focus on safe triage: assess how unwell the child is, identify non-blanching rash, and refer urgently where appropriate. OTC support is limited to symptom relief in children who are otherwise well.

Cradle cap (infantile seborrhoeic dermatitis) is a common, usually harmless condition in babies characterised by greasy, yellowish or brownish scaly patches on the scalp. It is most common in infants in the first few months of life and is not caused by poor hygiene or allergy. Most cases resolve spontaneously within a few weeks to months. The pharmacy role is to provide reassurance, advise on gentle scalp care, recommend appropriate OTC products where suitable, and identify the small number of cases that require medical review — particularly where the rash is severe, spreading, infected, or the baby is unwell.

Chickenpox (varicella) is a highly contagious viral infection caused by the varicella-zoster virus. It typically presents with a widespread itchy rash that starts as small red spots, progresses to fluid-filled blisters (vesicles), and then crusts over, often with crops of new lesions appearing over several days. Fever and malaise may precede or accompany the rash. Chickenpox is usually a mild, self-limiting illness in healthy children, though it can be significantly more severe in adults, in pregnancy, in newborns, and in immunosuppressed individuals. The pharmacy role is to assess severity, identify high-risk presentations requiring urgent medical review, advise on itch and fever management, and provide infection control advice. Do not attempt to diagnose chickenpox from the rash description alone, and do not initiate antiviral treatment — antivirals require GP/medical assessment.

Insomnia is a common pharmacy presentation covering difficulty falling asleep, staying asleep or waking earlier than intended, with resulting impact on daytime functioning. Short-term insomnia is often linked to stress, lifestyle factors or acute illness. Persistent insomnia requires medical review. The pharmacist role is to identify red flags, support sleep hygiene measures, counsel on the limited and short-term role of OTC sedating antihistamines, and refer appropriately. Do not attempt to diagnose insomnia disorder or manage mental health conditions.

Stopping smoking is one of the most beneficial health changes a person can make, reducing risks of cancer, cardiovascular disease, stroke and respiratory conditions. Nicotine replacement therapy (NRT) increases quit success rates. The pharmacy role includes brief advice, selection of appropriate NRT, counselling on correct use, and signposting to local stop-smoking services where available. NRT choice should be led by the individual's preference, product licence, and any relevant clinical factors. Behavioural support alongside NRT significantly improves outcomes. Do not create an automatic NRT product selector or structured prescribing pathway.

Malaria is a potentially life-threatening parasitic infection transmitted by infected Anopheles mosquitoes, predominantly in sub-Saharan Africa, South and Southeast Asia, Central and South America and parts of the Middle East and Pacific. Risk varies significantly by destination, region within a country, season, type of travel and individual traveller factors. Prevention combines bite avoidance measures and, where indicated, chemoprophylaxis selected according to the specific destination and traveller profile. This entry is a reference tool to support professional assessment — it does not replace up-to-date destination risk guidance from TravelHealthPro/NaTHNaC, local travel clinic protocols or pharmacist clinical judgement.

Post-herpetic neuralgia (PHN) is persistent nerve pain that continues after the skin rash of shingles (herpes zoster) has healed. It is characterised by burning, shooting or stabbing pain, and abnormal skin sensitivity (allodynia) over the previously affected dermatomal area. PHN is more common in older adults and can significantly affect sleep, mood and quality of life. OTC analgesics provide limited benefit for neuropathic pain; most effective treatments are prescription medicines. The pharmacy role is to assess whether active shingles is still present, identify red flags, provide supportive OTC comfort measures, and refer promptly. This entry does not duplicate the LocumPilot Pharmacy First shingles pathway — if active shingles is suspected, use that pathway.